While extant literature predominantly elucidates SIRT1's involvement in the progression of AD pathology through microRNAs, a comprehensive examination of lncRNAs influencing SIRT1 or p300 and subsequently modulating tau acetylation or deacetylation has not yet been conducted. This evidence concerns the gene EP300 and Alzheimer disease.